S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.13%) $0.928
USD/NOK
(0.16%) $10.86
USD/GBP
(-0.01%) $0.792
USD/RUB
(-0.03%) $92.55

Realtime updates for SillaJen, Inc. [215600.KQ]

Exchange: KOSDAQ
Last Updated28 Mar 2024 @ 22:04

0.00% KRW 5 150.00

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 22:04):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer...

Stats
Today's Volume 205 987
Average Volume 1.07M
Market Cap 529.38B
EPS KRW0 ( 2024-03-20 )
Next earnings date ( KRW0 ) 2024-05-12
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW6.64 (0.13%)

Volume Correlation

Long: 0.11 (neutral)
Short: 0.00 (neutral)
Signal:(45.437) Neutral

SillaJen, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

SillaJen, Inc. Correlation - Currency/Commodity

The country flag 0.50
( weak )
The country flag 0.29
( neutral )
The country flag 0.10
( neutral )
The country flag 0.15
( neutral )
The country flag 0.66
( moderate )
The country flag -0.30
( neutral )

SillaJen, Inc. Financials

Annual 2023
Revenue: KRW3.94B
Gross Profit: KRW-16.36B (-415.27 %)
EPS: KRW-198.16
Q4 2023
Revenue: KRW739.90M
Gross Profit: KRW-4.63B (-625.63 %)
EPS: KRW-57.96
Q3 2023
Revenue: KRW1.72B
Gross Profit: KRW-3.90B (-226.96 %)
EPS: KRW-51.92
Q2 2023
Revenue: KRW2.60B
Gross Profit: KRW-3.47B (-133.73 %)
EPS: KRW-51.29

Financial Reports:

No articles found.

SillaJen, Inc.

SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer. It also develops JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. The company was founded in 2006 and is headquartered in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators